BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Prognosis
53 results:

  • 1. A spectroscopic liquid biopsy for the earlier detection of multiple cancer types.
    Cameron JM; Sala A; Antoniou G; Brennan PM; Butler HJ; Conn JJA; Connal S; Curran T; Hegarty MG; McHardy RG; Orringer D; Palmer DS; Smith BR; Baker MJ
    Br J Cancer; 2023 Nov; 129(10):1658-1666. PubMed ID: 37717120
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Bait-trap chip for accurate and ultrasensitive capture of living circulating tumor cells.
    Jiang W; Han L; Li G; Yang Y; Shen Q; Fan B; Wang Y; Yu X; Sun Y; He S; Du H; Miao J; Wang Y; Jia L
    Acta Biomater; 2023 May; 162():226-239. PubMed ID: 36940769
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Complementary and Integrative Medicine in pancreatic cancer.
    Frenkel M; David A; Sapire K; Hausner D
    Curr Oncol Rep; 2023 Mar; 25(3):231-242. PubMed ID: 36735141
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic Markers after Hepatic Function Impairment in Patients with pancreatic Adenocarcinoma.
    Buyukkor M; Tay F; Karacin C; Duran AO
    J Coll Physicians Surg Pak; 2023 Jan; 33(1):32-36. PubMed ID: 36597232
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Liposome-based diagnostic and therapeutic applications for pancreatic cancer.
    Raza F; Evans L; Motallebi M; Zafar H; Pereira-Silva M; Saleem K; Peixoto D; Rahdar A; Sharifi E; Veiga F; Hoskins C; Paiva-Santos AC
    Acta Biomater; 2023 Feb; 157():1-23. PubMed ID: 36521673
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The C-Reactive Protein to Albumin Ratio Is an Independent Prognostic Factor in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: A Large Cohort Study.
    Li J; Yang S; Li Y; Li C; Xia Y; Zhu S; Xia J
    Cardiovasc Intervent Radiol; 2022 Sep; 45(9):1295-1303. PubMed ID: 35835873
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Leptomeningeal disease in brip1-mutated pancreatic adenocarcinoma.
    Yim E; Leung D
    BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35675963
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Considerations for personalized neoantigen vaccination in Malignant glioma.
    Dunn GP; Sherpa N; Manyanga J; Johanns TM
    Adv Drug Deliv Rev; 2022 Jul; 186():114312. PubMed ID: 35487282
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Cytotoxic terpenoids from Tripterygium hypoglaucum against human pancreatic cancer cells SW1990 by increasing the expression of Bax protein.
    Chen XL; Geng YJ; Li F; Hu WY; Zhang RP
    J Ethnopharmacol; 2022 May; 289():115010. PubMed ID: 35065248
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A Promising Diagnostic Role of Immunohistochemical Expression of Insulin-Like Growth Factor II mRNA Binding Protein 3 (IMP3) in pancreatic Lesions Using Endoscopic Ultrasound-Guided Fine Needle Aspiration (EUS-FNA) Cytology.
    Rashed HE; Nasr AN; Wasfi NT; ElHendawy R; Said NM
    J Gastrointest Cancer; 2023 Mar; 54(1):96-103. PubMed ID: 35028828
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A novel strategy to reveal clinical advantages and molecular mechanism of aidi injection in the treatment of pancreatic cancer based on network meta-analysis and network pharmacology.
    Wang H; Wu Z; Liu Y; Wang M; Stalin A; Guo S; Li J; Wu C; Zhang J; Tan Y; Huang Z; Lu S; Fan X; Wu J
    J Ethnopharmacol; 2022 Mar; 285():114852. PubMed ID: 34838619
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Alternative Lengthening of Telomeres (ALT) in pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice?
    Luchini C; Lawlor RT; Bersani S; Vicentini C; Paolino G; Mattiolo P; Pea A; Cingarlini S; Milella M; Scarpa A
    Curr Oncol Rep; 2021 Jul; 23(9):106. PubMed ID: 34269919
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer: achievements and future directions.
    Pandol SJ; Forsmark CE;
    Curr Opin Gastroenterol; 2021 Sep; 37(5):486-490. PubMed ID: 34156036
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Locally Advanced pancreatic cancer: Percutaneous Management Using Ablation, Brachytherapy, Intra-arterial Chemotherapy, and Intra-tumoral Immunotherapy.
    Timmer FEF; Geboers B; Nieuwenhuizen S; Schouten EAC; Dijkstra M; de Vries JJJ; van den Tol MP; de Gruijl TD; Scheffer HJ; Meijerink MR
    Curr Oncol Rep; 2021 Apr; 23(6):68. PubMed ID: 33864144
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Circulating CD14
    Stenzel AE; Abrams SI; Joseph JM; Goode EL; Tario JD; Wallace PK; Kaur D; Adamson AK; Buas MF; Lugade AA; Laslavic A; Taylor SE; Orr B; Edwards RP; Elishaev E; Odunsi K; Mongiovi JM; Etter JL; Winham SJ; Kaufmann SH; Modugno F; Moysich KB
    Am J Reprod Immunol; 2021 Mar; 85(3):e13343. PubMed ID: 32905653
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Combined Intraoperative Radiotherapy (IORT) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) with Cytoreduction Surgery (CRS) as a Novel Approach in the Management of Resectable pancreatic cancer.
    Azzam AZ; Amin TM
    Gulf J Oncolog; 2020 May; 1(33):19-26. PubMed ID: 32476645
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Survival in patients with carcinomas presenting with bone metastasis at diagnosis: a SEER population-based cohort study.
    Younis MH; Fuentes-Rivera L; Summers S; Pretell-Mazzini J
    Arch Orthop Trauma Surg; 2021 Mar; 141(3):367-373. PubMed ID: 32236712
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. prognosis Based Definition of Resectability in pancreatic cancer: A Road Map to New Guidelines.
    Oba A; Croce C; Hosokawa P; Meguid C; Torphy RJ; Al-Musawi MH; Ahrendt S; Gleisner A; Schulick RD; Del Chiaro M
    Ann Surg; 2022 Jan; 275(1):175-181. PubMed ID: 32149822
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Clinico-pathological features, treatments and survival of malignant insulinomas: a multicenter study.
    Veltroni A; Cosaro E; Spada F; Fazio N; Faggiano A; Colao A; Pusceddu S; Zatelli MC; Campana D; Piovesan A; Pia A; Grossrubatscher EM; Filice A; Bianchi A; Razzore P; Toaiari M; Cingarlini S; Landoni L; Micciolo R; Davì MV
    Eur J Endocrinol; 2020 Apr; 182(4):439-446. PubMed ID: 32061159
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. LncRNA LOXL1-AS1/miR-28-5p/SEMA7A axis facilitates pancreatic cancer progression.
    Liu Y; Guo C; Li F; Wu L
    Cell Biochem Funct; 2020 Jan; 38(1):58-65. PubMed ID: 31732974
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.